Research
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
February 8, 2022
February 3, 2022
February 3, 2022
February 2, 2022
February 1, 2022
January 31, 2022
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community